GSK sells rare disease gene therapy portfolio via @FT
https://t.co/IfzG6lzbIr— The Propell Group (@ThePropellGroup) April 13, 2018
GSK sells rare disease gene therapy portfolio via @FT
https://t.co/IfzG6lzbIr— The Propell Group (@ThePropellGroup) April 13, 2018